Abstract
Although currently no medication has been approved to treat autism spectrum disorders, survey data show that community practitioners are prescribing a broad range of medication treatments, including, but not limited to, antidepressants, stimulants, antipsychotics, alpha agonists, and anticonvulsants. Patients with autism spectrum disorders are also taking alternative treatments, including herbal remedies, immunologic treatments, and vitamin therapies, which may themselves produce side effects and/or create drug interactions with traditional medications. Although short-term data on the efficacy and safety of commonly prescribed treatments for autism spectrum disorders are increasing, few data are currently available on long-term treatment for autism spectrum disorders, but available studies and clinical experience can offer preliminary recommendations on the safety of and monitoring needs for the medications currently used for these disorders. Monitoring the safety and tolerability of drugs used in patients with these disorders should minimize the burden of side effects and optimize treatment outcome.
TY - JOUR
T1 - Safety issues with drug therapies for autism spectrum disorders.
A1 - McCracken,James T,
PY - 2006/1/13/pubmed
PY - 2006/3/11/medline
PY - 2006/1/13/entrez
SP - 32
EP - 7
JF - The Journal of clinical psychiatry
JO - J Clin Psychiatry
VL - 66 Suppl 10
N2 - Although currently no medication has been approved to treat autism spectrum disorders, survey data show that community practitioners are prescribing a broad range of medication treatments, including, but not limited to, antidepressants, stimulants, antipsychotics, alpha agonists, and anticonvulsants. Patients with autism spectrum disorders are also taking alternative treatments, including herbal remedies, immunologic treatments, and vitamin therapies, which may themselves produce side effects and/or create drug interactions with traditional medications. Although short-term data on the efficacy and safety of commonly prescribed treatments for autism spectrum disorders are increasing, few data are currently available on long-term treatment for autism spectrum disorders, but available studies and clinical experience can offer preliminary recommendations on the safety of and monitoring needs for the medications currently used for these disorders. Monitoring the safety and tolerability of drugs used in patients with these disorders should minimize the burden of side effects and optimize treatment outcome.
SN - 0160-6689
UR - https://www.unboundmedicine.com/medline/citation/16401148/Safety_issues_with_drug_therapies_for_autism_spectrum_disorders_
L2 - http://www.psychiatrist.com/jcp/article/pages/2005/v66s10/v66s1005.aspx
DB - PRIME
DP - Unbound Medicine
ER -
